ArticleBMC oral health2026
Influence of calcium hydroxide/nano-chitosan as intracanal medication on push-out bond strength of epoxy resin and bioceramic sealers: an ex-vivo study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe present study aimed to evaluate the impact of intracanal medicaments-calcium hydroxide (CH) and calcium hydroxide/nano-chitosan (CH/NC)-on the push-out bond strength (POBS) of AH Plus (AHP) and NeoSEALER Flo (NSF).
methodsNano-chitosan (NC) characterization was done using transmission electron microscopy (TEM), dynamic light scattering (DLS) and zeta potential analysis. Sixty extracted maxillary central incisors were instrumented up to X5 (50/0.06). Based on intracanal medicament used, specimens were allocated into three groups (n = 20): Group I; no intracanal medicament (control), Group II; (CH), and Group III; (CH/NC). Intracanal medicaments were removed after one week of incubation. Each group was subdivided based on sealer used (n = 10): subgroup A (AHP) and subgroup B (NSF). Obturation was performed with cold lateral compaction. After one week of incubation, roots were sectioned and a universal testing machine was used to evaluate POBS. Three-way ANOVA and Chi-square tests were conducted at 0.05 significance level.
resultsTEM showed mostly spherical NC particles with diameters less than 50 nm. DLS analysis revealed a hydrodynamic Z-average diameter of 62.4 nm with a polydispersity index of 0.195. Zeta potential analysis demonstrated a positive surface charge of + 47.57 mV. The "medication" factor, "medication/sealer", "medication/root level" and "sealer/root level" interactions significantly affected POBS (P < 0.05). Neither "sealer" nor "root level" factors significantly affected POBS (P > 0.05). Pooled POBS data revealed that: IA and IB subgroups were significantly higher than IIA, IIB, IIIA and IIIB subgroups (P < 0.05). Regarding failure mode, tested subgroups showed no significant difference (P > 0.05).
conclusionsUnder the conditions of this study, prior application of CH or CH/NC reduced POBS for both sealers compared with controls. The addition of NC to CH did not provide a statistically significant improvement in POBS compared to CH alone. Overall, AHP and NSF demonstrated comparable POBS to root canal dentin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.